Skip to content

Drug interactions

Flavoxate + Oxybutynin transdermal

Severity: Moderate

Flavoxate and Oxybutynin transdermal: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Both agents are used for bladder overactivity and have antimuscarinic effects. Combining them adds to the risk of dry mouth, constipation, blurred vision, urinary retention and cognitive effects, although transdermal oxybutynin gives somewhat less of the dry mouth caused by its metabolite.

What this interaction means in plain words

Flavoxate and Oxybutynin transdermal can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Evidence level: Moderate

Why it happens

Additive antimuscarinic effects.

What to do

Avoid using two antimuscarinic bladder agents together unless clearly justified. If combined, monitor for anticholinergic adverse effects and post-void residual urine.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Flavoxate and Oxybutynin transdermal, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Flavoxate with Oxybutynin transdermal?

MediHelp rates the interaction as moderate. Flavoxate and Oxybutynin transdermal can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Both agents are used for bladder overactivity and have antimuscarinic effects. Combining them adds to the risk of dry mouth, constipation, blurred vision, urinary retention and cognitive effects, although transdermal oxybutynin gives somewhat less of the dry mouth caused by its metabolite.

How serious is the interaction between Flavoxate and Oxybutynin transdermal?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid using two antimuscarinic bladder agents together unless clearly justified. If combined, monitor for anticholinergic adverse effects and post-void residual urine.

What other medicines interact with Flavoxate?

MediHelp also lists interactions of Flavoxate with, for example, Clozapine, Abobotulinumtoxina, Aclidinium. The full list is on the Flavoxate page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in